Bookmark

Add to MyYahoo RSS

Affymax News

News on Affymax (Ticker: AFFY) continually updated from thousands of sources around the net.

Tuesday Jun 24 | Business Wire

Affymax Board Announces Decision to Dissolve the Company

Based on the information the Company currently has available, which is subject to change, the Company estimates that the aggregate amount of the distribution to stockholders could be a few cents per share, based on 37,490,095 shares of common stock outstanding as of April 30, 2014 and the remaining cash of approximately $4 million as of May 2014.

Comment?

Related Topix: Startups, Corporate / Securities Law, Law, Securities and Exchange Commission, Healthcare Law

Mon Jun 16, 2014

BioSpace

Affymax, Inc. Drug Omontys Terminal As Takeda Pharmaceutical Co. Ltd. Switches Off Support

Affymax, Inc. And Takeda Pharmaceutical Co. Ltd. Announce Termination Of Omontys Product Collaboration And License Agreement Takeda will withdraw the Omontys U.S. New Drug Application CUPERTINO, Calif.-- --Affymax, Inc. and Takeda Pharmaceutical Company Limited Osaka, Japan announced today that their OmontysA product collaboration and license ... (more)

Comment?

Related Topix: Startups, Santa Clara County, CA, Cupertino, CA, Millennium Pharmaceuticals, Pharmaceuticals, Takeda Pharmaceutical Company, Food and Drug Administration

Fri Jun 13, 2014

Freshnews

Affymax and Takeda Announce Termination of OmontysA (peginesatide)...

Affymax, Inc. and Takeda Pharmaceutical Company Limited Osaka, Japan announced today that their Omontys product collaboration and license agreement will terminate effective September 10, 2014.

Comment?

Related Topix: Startups, Takeda Pharmaceutical Company, Pharmaceuticals

•••
•••
•••
•••
•••

Seattle Jobs

•••
•••
•••
•••